Ortin Global Limited
Ortin Global Limited engages in the manufacture and trading of pharmaceuticals, drugs, and intermediates in India. The company offers various pharmaceutical formulations of tablets, capsules, syrups, and dry powders; formulations, such as anti-diabetics, anti-allergics, anti-anginal and cardiovascular, sedatives and tranquilisers, anti-helmenthetics, analgesics and antipyretics, anti-biotics-quin… Read more
Ortin Global Limited (ORTINGLOBE) - Total Liabilities
Latest total liabilities as of September 2025: ₹25.26 Million INR
Based on the latest financial reports, Ortin Global Limited (ORTINGLOBE) has total liabilities worth ₹25.26 Million INR as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Ortin Global Limited - Total Liabilities Trend (2021–2025)
This chart illustrates how Ortin Global Limited's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Ortin Global Limited Competitors by Total Liabilities
The table below lists competitors of Ortin Global Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Aptose Biosciences Inc
NASDAQ:APTO
|
USA | $14.67 Million |
|
BILFINGER (GBF.SG)
STU:GBF
|
Germany | €2.17 Billion |
|
Group One Capital Limited
AU:G1C
|
Australia | AU$65.55K |
|
Pacific Smiles Group Ltd
AU:PSQ
|
Australia | AU$104.03 Million |
|
BT Wealth Industries Public Company Limited
BK:BTW
|
Thailand | ฿449.79 Million |
|
Kakel Max AB (publ)
ST:KAKEL
|
Sweden | Skr47.19 Million |
|
Gaon Group Ltd
TA:GAGR
|
Israel | ILA604.16 Million |
|
SBC Medical Group Holdings Incorporated
NASDAQ:SBCWW
|
USA | $73.30 Million |
Liability Composition Analysis (2021–2025)
This chart breaks down Ortin Global Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.09 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.94 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.66 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Ortin Global Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Ortin Global Limited (2021–2025)
The table below shows the annual total liabilities of Ortin Global Limited from 2021 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | ₹18.03 Million | -53.04% |
| 2024-03-31 | ₹38.40 Million | -62.83% |
| 2023-03-31 | ₹103.32 Million | +5.99% |
| 2022-03-31 | ₹97.48 Million | -1.64% |
| 2021-03-31 | ₹99.10 Million | -- |